Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma

Neuro-Oncology

Volumn 16, Issue 8, 2014, Pages 1129-1136

  Schreiber, Jane E ^a   Gurney, James G ^a,b   Palmer, Shawna L ^a   Bass, Johnnie K ^a   Wang, Mingjuan ^a   Chen, Si ^a   Zhang, Hui ^a   Swain, Michelle ^c   Chapieski, Mary L ^d   Bonner, Melanie J ^e   Mabbott, Donald J ^f   Knight, Sarah J ^g   Armstrong, Carol L ^h   Boyle, Robyn ⁱ   Gajjar, Amar ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁱ SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Academic; Cognitive; Hearing; Medulloblastoma; Posterior fossa syndrome

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ARTICLE; BRAIN DISEASE; CANCER CHEMOTHERAPY; CHILD; CRANIOSPINAL IRRADIATION; FEMALE; HEARING IMPAIRMENT; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; POSTERIOR CRANIAL FOSSA SYNDROME; RACE; RISK FACTOR; STEM CELL TRANSPLANTATION; ADOLESCENT; ANIMAL; CEREBELLAR NEOPLASMS; COGNITION; COMPLICATION; HEARING LOSS; LONGITUDINAL STUDY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ANIMALS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION; COMBINED MODALITY THERAPY; CRANIOSPINAL IRRADIATION; FEMALE; HEARING LOSS; HUMANS; LONGITUDINAL STUDIES; MALE; MEDULLOBLASTOMA; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904322667     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou006     Document Type: Article

References (35)

1. Robinson KE, Kuttesch JF, Champion JE, et al. A quantitative meta-Analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer. 2010;55(3):525-531
2. Robinson KE, Fraley CE, Pearson MM, et al. Neurocognitive late effects of pediatric brain tumors of the posterior fossa: A quantitative review. J Int Neuropsychol Soc. 2013;19(1):44-53
3. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75(8):2186-2195
4. Northcott PA, Jones DT, Kool M, et al. Medulloblastomics: The end of the beginning. Nat Rev Cancer. 2012;12(12):818-834
5. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-Adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-Term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813-820 (Pubitemid 44464063)
6. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol. 1998;16(5): 1723-1728
7. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol. 2001;19(2):472-479 (Pubitemid 32112861)
8. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-Adapted therapy for childhood medulloblastoma. J Clin Oncol. 2005;23(24):5511-5519
9. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol. 2001;19(8):2302-2308 (Pubitemid 32366983)
10. Ris MD, Packer R, Goldwein J, et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Childrens Cancer Group study. J Clin Oncol. 2001;19(8):3470-3476 (Pubitemid 32730083)
11. Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23(34):8588-8596 (Pubitemid 46211500)
12. Blakley BW, Myers SF. Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg. 1993; 109(3 Pt 1):385-391 (Pubitemid 23318944)
13. Higby DJ, Wallace HJ Jr., Albert D, et al. Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol. 1974;112(1): 100-104
14. Waters GS, Ahmad M, Katsarkas A, et al. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: Influence of dosage and schedule of administration. Ear Hear. 1991;12(2):91-102
15. Jereczek-Fossa BA, Zarowski A, Milani F, et al. Radiotherapy-induced ear toxicity. Cancer Treat Rev. 2003;29(5):417-430 (Pubitemid 37185108)
16. Gajjar A, Kuhl J, Epelman S, et al. Chemotherapy of medulloblastoma. Childs Nerv Syst. 1999;15(10):554-562 (Pubitemid 29493581)
17. Low WK, Toh ST, Wee J, et al. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study. J Clin Oncol. 2006;24(12):1904-1909 (Pubitemid 46638990)
18. Warrier R, Chauhan A, Davluri M, et al. Cisplatin and cranial irradiation-related hearing loss in children. Ochsner J. 2012;12(3): 191-196
19. De Smet HJ, Baillieux H, Catsman-Berrevoets C, et al. Postoperative motor speech production in children with the syndrome of cerebellar mutism and subsequent dysarthria: A critical review of the literature. Eur J Paediatr Neurol. 2007;11(4):193-207 (Pubitemid 46844675)
20. Korah MP, Esiashvili N, Mazewski CM, et al. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma. Int J Radiat Oncol Biol Phys. 2010;77(1):106-112
21. Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: A prospective study by the Childrens Oncology Group. J Neurosurg. 2006;105(6-suppl):444-451 (Pubitemid 44968374)
22. Palmer SL, Hassall T, Evankovich K, et al. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol. 2010;12(12):1311-1317
23. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351-1359
24. Woodcock R, McGraw K, Mather N. Woodcock-Johnson Third Edition, Tests of Cognitive Abilities. Itasca, IL: Riverside Publishing; 2001
25. Woodcock R, McGraw K, Mather N. Woodcock-Johnson Third Edition, Tests of Achievement. Itasca, IL: Riverside Publishing; 2001
26. Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol. 2010; 28(10):1788-1795
27. Chall JS. Stages of reading development. 2nd ed. Fort Worth, TX: Harcourt Brace; 1996
28. Holstrum WJ, Gaffney M, Gravel JS, et al. Early intervention for children with unilateral and mild bilateral degrees of hearing loss. Trends Amplif. 2008;12(1):35-41 (Pubitemid 351191332)
29. Kuppler K, Lewis M, Evans AK. A review of unilateral hearing loss and academic performance: Is it time to reassess traditional dogmata?. Int J Pediatr Otorhinolaryngol. 2013;77(5):617-622
30. Tharpe AM. Unilateral and mild bilateral hearing loss in children: Past and current perspectives. Trends Amplif. 2008;12(1):7-15 (Pubitemid 351200436)
31. Gurney JG, Tersak JM, Ness KK, et al. Hearing loss, quality of life, and academic problems in long-Term neuroblastoma survivors: A report from the Childrens Oncology Group. Pediatrics. 2007;120(5): E1229-e1236 (Pubitemid 350085519)
32. Russ SA, Kenney MK, Kogan MD. Hearing difficulties in children with special health care needs. J Dev Behav Pediatr. 2013;34(7):478-485
33. Conklin HM, Li C, Xiong X, et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol. 2008;26(24):3965-3970
34. Mabbott DJ, Spiegler BJ, Greenberg ML, et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol. 2005;23(10):2256-2263 (Pubitemid 46218718)
35. Lewis F, Murdoch B. Language skills following risk-Adapted treatment for medulloblastoma. Dev Neurorehabil. 2010;13(3):217-224